Enfortumab vedotin in combination with pembrolizumab in urothelial cancer
Ettinger S, Mayer-Ferbas J, Jeindl R
Record ID 32018014813
English
Details
Project Status:
Completed
URL for project:
https://aihta.at/page/hta-informationsdienst/en
Year Published:
2025
URL for published report:
https://eprints.aihta.at/1575/1/HTA-Informationsdienst_Rapid%20Review_019.pdf
URL for additional information:
https://eprints.aihta.at/1575/
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Austria
MeSH Terms
- Urinary Bladder Neoplasms
- Infusions, Intravenous
- Urologic Neoplasms
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal
- Immune Checkpoint Inhibitors
Contact
Organisation Name:
Austrian Institute for Health Technology Assessment
Contact Address:
Josefstaedter Strasse 39, A-1080 Vienna, Austria
Contact Name:
office@aihta.at
Contact Email:
office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.